CMMB

Chemomab Therapeutics

5 hedge funds and large institutions have $346K invested in Chemomab Therapeutics in 2020 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 4 closing their positions.

Holders
5
Holders Change
-1
Holders Change %
-16.67%
% of All Funds
0.09%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
1
Reduced
Closed
4
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
Renaissance Technologies
1
Renaissance Technologies
New York
$148K 85,475 +85,475 New
VF
2
Virtu Financial
New York
$120K 69,653 +56,520 +430%
RC
3
RegentAtlantic Capital
New Jersey
$43K 25,000
Citadel Advisors
4
Citadel Advisors
Florida
$21K 12,168 +12,168 New
Morgan Stanley
5
Morgan Stanley
New York
$14K 8,153 +8,153 New
PCM
6
Palisade Capital Management
New Jersey
-369,640 Closed
MIH
7
Meitav Investment House
Israel
-234,402 Closed
PF
8
Phoenix Financial
Israel
-26,087 Closed
Osaic Holdings
9
Osaic Holdings
Arizona
-2,350 Closed
CFGS
10
Concourse Financial Group Securities
Alabama